Squarepoint’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26.3M Sell
240,200
-77,100
-24% -$11M 0.03% 569
2025
Q4
$52.8M Buy
317,300
+183,500
+137% +$30.7M 0.06% 387
2025
Q3
$26.2M Buy
133,800
+124,400
+1,323% +$20.5M 0.03% 622
2025
Q2
$850K Sell
9,400
-140,400
-94% -$11.1M ﹤0.01% 2809
2025
Q1
$8.94M Buy
149,800
+132,900
+786% +$12.3M 0.01% 1083
2024
Q4
$2.24M Buy
+16,900
New +$1.59M ﹤0.01% 2314

Other funds holding ALAB

Squarepoint's ALAB Position: Q1 2026 in Review

Squarepoint reduced its Astera Labs (ALAB) stake by 31% in Q1 2026, selling an estimated $9.27M and leaving 141,557 shares worth $15.5M. The position accounts for 0.02% of the portfolio, ranked #831.

Squarepoint first reported a position in ALAB in Q1 2024 and has held it in 9 quarters since. The position peaked at $42.3M in Q2 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Squarepoint held 141,557 shares of Astera Labs worth $15.5M as of Q1 2026.
  • Squarepoint sold 65,074 Astera Labs shares in Q1 2026, an estimated $9.27M.
  • Astera Labs made up 0.02% of Squarepoint's portfolio in Q1 2026, its #831 holding.
  • Squarepoint first reported a position in Astera Labs in Q1 2024 and has held it in 9 quarters since.
  • Squarepoint's Astera Labs position peaked at $42.3M in Q2 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.